Logo-ipp
Submitted: 20 Mar 2020
Accepted: 24 Mar 2020
ePublished: 28 Mar 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Immunopathol Persa. 2020;6(2): e16.
doi: 10.34172/ipp.2020.16
  Abstract View: 62
  PDF Download: 35

Epidemiology and Prevention

Acute respiratory distress syndrome in COVID-19

Nahid Dadashzadeh 1, Saman Farshid 2 ORCID logo, Rohollah Valizadeh 3,4 ORCID logo, Mohammad Nanbakhsh 5, Mohsen Mohammad Rahimi 6 * ORCID logo

1 Legal Medicine Research Center, Iranian Legal Medicine Organization, Tehran, Iran
2 Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran
3 Student Research Committee, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
4 Nickan Research Institute, Isfahan, Iran
5 Department of Pulmonology, Shahid Motahari Children Hospital, Urmia University of Medical Sciences, Urmia, Iran
6 Kidney Research Center , Tabriz University of Medical Sciences, Tabriz, Iran
*Correspondence to Mohsen Mohammad Rahimi, Email: Mohammadrahimi@ tbzmed.ac.ir

Abstract

Emerging coronavirus-related respiratory disease started from Wuhan, China in December 2019 resulted in numerous mortality following acute respiratory distress syndrome (ARDS) named COVID-19 disease. The incubation period of COVID-19 is varied from 2 days to 2 weeks; therefore oral transmission is the most hazardous issue in this incubation period. Scientists are trying to find a specific drug to treat COVID-19 disease, however there is no specific therapy yet. One of the challenging issues in the treatment process of these patients is ARDS. In the development of any type of pneumonia or ARDS, Covid-19 should be considered as an option for differential diagnosis and the first critical organ in these patients is lung. In this paper, we discussed ARDS in patients with COVID-19.
Keywords: COVID-19, Coronavirus Pneumonia, Infection, 2019 novel coronavirus, Acute respiratory distress syndrome
Citation: Dadashzadeh N, Farshid S, Valizadeh R, Nanbakhsh M, Rahimi MM. Acute respiratory distress syndrome in COVId-19 disease. Immunopathol Persa. 2020; 6(2):e16. doi: 10.34172/ipp.2020.16
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 62

Your browser does not support the canvas element.


PDF Download: 35

Your browser does not support the canvas element.